These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 3033269

  • 1. Identification of gp350 as the viral glycoprotein mediating attachment of Epstein-Barr virus (EBV) to the EBV/C3d receptor of B cells: sequence homology of gp350 and C3 complement fragment C3d.
    Nemerow GR, Mold C, Schwend VK, Tollefson V, Cooper NR.
    J Virol; 1987 May; 61(5):1416-20. PubMed ID: 3033269
    [Abstract] [Full Text] [Related]

  • 2. Isolating the Epstein-Barr virus gp350/220 binding site on complement receptor type 2 (CR2/CD21).
    Young KA, Chen XS, Holers VM, Hannan JP.
    J Biol Chem; 2007 Dec 14; 282(50):36614-25. PubMed ID: 17925391
    [Abstract] [Full Text] [Related]

  • 3. Incorporation of the purified Epstein Barr virus/C3d receptor (CR2) into liposomes and demonstration of its dual ligand binding functions.
    Mold C, Cooper NR, Nemerow GR.
    J Immunol; 1986 Jun 01; 136(11):4140-5. PubMed ID: 3009615
    [Abstract] [Full Text] [Related]

  • 4. Structural requirements for C3d,g/Epstein-Barr virus receptor (CR2/CD21) ligand binding, internalization, and viral infection.
    Carel JC, Myones BL, Frazier B, Holers VM.
    J Biol Chem; 1990 Jul 25; 265(21):12293-9. PubMed ID: 1695627
    [Abstract] [Full Text] [Related]

  • 5. Identification and characterization of the Epstein-Barr virus receptor on human B lymphocytes and its relationship to the C3d complement receptor (CR2).
    Nemerow GR, Wolfert R, McNaughton ME, Cooper NR.
    J Virol; 1985 Aug 25; 55(2):347-51. PubMed ID: 2410629
    [Abstract] [Full Text] [Related]

  • 6. Identification of an epitope in the major envelope protein of Epstein-Barr virus that mediates viral binding to the B lymphocyte EBV receptor (CR2).
    Nemerow GR, Houghten RA, Moore MD, Cooper NR.
    Cell; 1989 Feb 10; 56(3):369-77. PubMed ID: 2464439
    [Abstract] [Full Text] [Related]

  • 7. Epstein Barr virus/complement C3d receptor is an interferon alpha receptor.
    Delcayre AX, Salas F, Mathur S, Kovats K, Lotz M, Lernhardt W.
    EMBO J; 1991 Apr 10; 10(4):919-26. PubMed ID: 1849076
    [Abstract] [Full Text] [Related]

  • 8. Epstein-Barr virus gp350/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping, and endocytosis.
    Tanner J, Weis J, Fearon D, Whang Y, Kieff E.
    Cell; 1987 Jul 17; 50(2):203-13. PubMed ID: 3036369
    [Abstract] [Full Text] [Related]

  • 9. How Epstein-Barr virus envelope glycoprotein gp350 tricks the CR2? A molecular dynamics study.
    Bingöl EN, Taştekil I, Yay C, Keskin N, Ozbek P.
    J Mol Graph Model; 2022 Jul 17; 114():108196. PubMed ID: 35500362
    [Abstract] [Full Text] [Related]

  • 10. Structure of the human B lymphocyte receptor for C3d and the Epstein-Barr virus and relatedness to other members of the family of C3/C4 binding proteins.
    Weis JJ, Toothaker LE, Smith JA, Weis JH, Fearon DT.
    J Exp Med; 1988 Mar 01; 167(3):1047-66. PubMed ID: 2832506
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of Epstein-Barr virus infection in vitro and in vivo by soluble CR2 (CD21) containing two short consensus repeats.
    Moore MD, Cannon MJ, Sewall A, Finlayson M, Okimoto M, Nemerow GR.
    J Virol; 1991 Jul 01; 65(7):3559-65. PubMed ID: 1645784
    [Abstract] [Full Text] [Related]

  • 12. Studies of the Epstein Barr virus receptor found on Raji cells. II. A comparison of lymphocyte binding sites for Epstein Barr virus and C3d.
    Hutt-Fletcher LM, Fowler E, Lambris JD, Feighny RJ, Simmons JG, Ross GD.
    J Immunol; 1983 Mar 01; 130(3):1309-12. PubMed ID: 6218205
    [Abstract] [Full Text] [Related]

  • 13. Identification of a spontaneously shed fragment of B cell complement receptor type two (CR2) containing the C3d-binding site.
    Myones BL, Ross GD.
    Complement; 1987 Mar 01; 4(2):87-98. PubMed ID: 3497773
    [Abstract] [Full Text] [Related]

  • 14. Binding of monoclonal antibody to the Epstein Barr virus (EBV)/CR2 receptor induces activation and differentiation of human B lymphocytes.
    Nemerow GR, McNaughton ME, Cooper NR.
    J Immunol; 1985 Nov 01; 135(5):3068-73. PubMed ID: 2995485
    [Abstract] [Full Text] [Related]

  • 15. Determination of the structural basis for selective binding of Epstein-Barr virus to human complement receptor type 2.
    Martin DR, Yuryev A, Kalli KR, Fearon DT, Ahearn JM.
    J Exp Med; 1991 Dec 01; 174(6):1299-311. PubMed ID: 1660522
    [Abstract] [Full Text] [Related]

  • 16. Epstein Barr virus binding induces internalization of the C3d receptor: a novel immunotoxin delivery system.
    Tedder TF, Goldmacher VS, Lambert JM, Schlossman SF.
    J Immunol; 1986 Aug 15; 137(4):1387-91. PubMed ID: 3016095
    [Abstract] [Full Text] [Related]

  • 17. Purification of the Epstein-Barr virus/C3d complement receptor of human B lymphocytes: antigenic and functional properties of the purified protein.
    Nemerow GR, Siaw MF, Cooper NR.
    J Virol; 1986 May 15; 58(2):709-12. PubMed ID: 2422399
    [Abstract] [Full Text] [Related]

  • 18. Evidence for multiple sites of interaction in C3 for complement receptor type 2 (C3d/EBV receptor, CD21).
    Esparza I, Becherer JD, Alsenz J, De la Hera A, Lao Z, Tsoukas CD, Lambris JD.
    Eur J Immunol; 1991 Nov 15; 21(11):2829-38. PubMed ID: 1834472
    [Abstract] [Full Text] [Related]

  • 19. Analysis of Epstein-Barr virus-binding sites on complement receptor 2 (CR2/CD21) using human-mouse chimeras and peptides. At least two distinct sites are necessary for ligand-receptor interaction.
    Molina H, Brenner C, Jacobi S, Gorka J, Carel JC, Kinoshita T, Holers VM.
    J Biol Chem; 1991 Jul 05; 266(19):12173-9. PubMed ID: 1712014
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.